• Ethical Issues and Risk/Benefit Assessment of Iron Chelation Therapy: Advances with Deferiprone/Deferoxamine Combinations and Concerns about the Safety, Efficacy and Costs of Deferasirox, George J. Kontoghiorghes

  Volume 32, Issue 1

• Magnetic Resonance Imaging Assessment of Excess Iron in Thalassemia, Sickle Cell Disease and Other Iron Overload Diseases, John C. Wood, and Nilesh Ghugre

  Volume 32, Issue 1

• The Role of Zinc, Copper and Iron in the Pathogenesis of Diabetes and Diabetic Complications: Therapeutic Effects by Chelators, Yang Zheng, Xiao-Kun Li, Yuehui Wang, and Lu Cai

  Volume 32, Issue 1

• Sickle Cell Disease: A Multigenic Perspective of a Single Gene Disorder, Abdullah Kutlar

  Volume 31, Issue 2

• Chelators Controlling Metal Metabolism and Toxicity Pathways: Applications in Cancer Prevention, Diagnosis and Treatment, George J. Kontoghiorghes, Aglaia Efstathiou, Stella Ioannou-Loucaides, and Annita Kolnagou                                                      Volume 32, Issue 1

Hemoglobin reports on the most current research regarding diseases affecting hemoglobin, the red cell components' interaction, and of course, hemoglobin itself. The journal includes all fundamental, practical, genetic, epidemiological, and clinical matters related to hemoglobin.

Fill out our library recommendation form today and we will contact your library about subscribing. 

Sincerely,

P.S.  Hurry, free access offer expires April 6, 2009!

For further information on the Journal, go to www.informaworld.com/hemoglobin